Results from the OCEANIC-STROKE trial show that the investigational Factor XIa inhibitor, asundexian, not only reduces the ...

Are all hormones created equal? Drs Rachel Rubin and Kelly Casperson unpack the missing details in recent menopause research ...

A monthly snapshot of FDA activity involving therapies for the prevention and treatment of neurologic diseases.

The use of calcitonin gene-related peptide (CGRP) inhibitors to treat adults with migraine is linked to a 25% lower risk for ...

Plant-based protein consumption is associated with a lower risk for CVD, but its effects depend on food quality, processing, ...

Upadacitinib is effective in inducing clinical response and remission and is generally well tolerated in patients with ...

A US study found that giving oseltamivir to ≥ 70% of nursing home residents within 48 hours of an outbreak cut ...

A comparative analysis identifies the top IL-23 inhibitors that were least likely to be associated with the development of ...

The Alberta government has proposed a voucher program for patients who have waited longer than is recommended for surgery.

ESPEN’s new ethics guide reframes medical nutrition as a clinical intervention, urging clinicians to prioritize patient ...

The American Board of Pediatrics’ new subspecialty training model aims to improve readiness for practice as well as ...

Dual-energy CT with virtual non-calcium reconstruction provides high specificity in detecting bone marrow oedema in ...